Kerbauy, L., Marin, N., Kaplan, M., Banerjee, P., Berrien-Elliott, M., Becker-Hapak, M., Basar, R., Foster, M., Melo, L. G., Neal, C., McClain, E., Daher, M., Nunez Cortes, A. K., Desai, S., Inng Lim, F. W., Mendt, M. C., Schappe, T., Li, L., Shaim, H., Sanabria, M. H., Wong, P., Liu, E., Ang, S., Cai, R., Nandivada, V., Mohanty, V., Shen, Y., Baran, N., Fowlkes, N., Chen, K., Muniz-Feliciano, L., Koch, J., Treder, M., Fischer, W., Okamoto, O. K., Nieto, Y., Champlin, R., Shpall, E., Fehniger, T., & Rezvani, K. (n.d.). 531 AFM13-targeted blood and cord-blood-derived memory-like NK cells as therapy for CD30+ malignancies. Journal for immunotherapy of cancer, 8, A324–A325. http://access.bl.uk/ark:/81055/vdc_100144713883.0x000003